相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Soluble RANKL is physiologically dispensable but accelerates tumour metastasis to bone
Tatsuo Asano et al.
NATURE METABOLISM (2019)
Local administration of WP9QY (W9) peptide promotes bone formation in a rat femur delayed-union model
Mikiya Sawa et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2018)
Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss
Jinhu Xiong et al.
NATURE COMMUNICATIONS (2018)
Coupling of bone resorption and formation by RANKL reverse signalling
Yuki Ikebuchi et al.
NATURE (2018)
Roles of the RANKL-RANK axis in antitumour immunity - implications for therapy
Elizabeth Ahern et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer
Shuan Rao et al.
GENES & DEVELOPMENT (2017)
Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases
Hibiki Udagawa et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
v' Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis
Yuki Ozaki et al.
PLOS ONE (2017)
The W9 peptide directly stimulates osteoblast differentiation via RANKL signaling
Midori Nakamura et al.
JOURNAL OF ORAL BIOSCIENCES (2017)
Peptide drugs accelerate BMP-2-induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling
Yasutaka Sugamori et al.
BIOESSAYS (2016)
Combination Anti-CTLA-4 and Anti-RANKL in Metastatic Melanoma
Mark J. Smyth et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance
Imran S. Khan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity
Yuriko Furuya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The local administration of TNF-α and RANKL antagonist peptide promotes BMP-2-induced bone formation
Abdulla Al Masud Khan et al.
JOURNAL OF ORAL BIOSCIENCES (2013)
Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid Subgroup Analysis from a Randomized Phase 3 Study
Giorgio Vittorio Scagliotti et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
Matthew R. Smith et al.
LANCET (2012)
Increased Bone Mass in Mice after Single Injection of Anti-receptor Activator of Nuclear Factor-κB Ligand-neutralizing Antibody EVIDENCE FOR BONE ANABOLIC EFFECT OF PARATHYROID HORMONE IN MICE WITH FEW OSTEOCLASTS
Yuriko Furuya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Establishment of a new murine model of hypercalcemia with anorexia by overexpression of soluble receptor activator of NF-κB ligand using an adenovirus vector
Tetsuro Enomoto et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2011)
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling
Wei Tan et al.
NATURE (2011)
Matrix-embedded cells control osteoclast formation
Jinhu Xiong et al.
NATURE MEDICINE (2011)
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Tomoki Nakashima et al.
NATURE MEDICINE (2011)
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
Eva Gonzalez-Suarez et al.
NATURE (2010)
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
Daniel Schramek et al.
NATURE (2010)
Evaluation of Pharmaceuticals With a Novel 50-Hour Animal Model of Bone Loss
Yoshiya Tomimori et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance
Taishin Akiyama et al.
IMMUNITY (2008)
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Jun-Li Luo et al.
NATURE (2007)
A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss
Kazuhiro Aoki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Regulation of cancer cell migration and bone metastasis by RANKL
DH Jones et al.
NATURE (2006)
Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system
G Eissner et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis
A Mizuno et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2002)
分享论文
